David M Cash
机构: Senior Research Associate, Dementia Research Centre and Centre for Medical Image Computing, UCL
每年引用次数
引用次数
引用: 12,172
H-指数: 53
I10-指数 : 149
出版物: 431
Study protocol: Insight 46 – a neuroscience sub-study of the MRC National Survey of Health and Development
Christopher A. Lane , Thomas D. Parker , Dave M. Cash , Kirsty Macpherson
BMC Neurology 17 ( 1) 75 -75
76
2017
MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1.
Michael Flower , Vilija Lomeikaite , Marc Ciosi , Sarah Cumming
Brain 142 ( 7) 1876 -1886
42
2019
Imaging endpoints for clinical trials in Alzheimer's
Sebastien Ourselin , Nick C Fox , Natalie S Ryan , David M Cash
2
2014
Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study
Sebastian J Crutch , Marc Modat , Marc Modat , Ian B Malone
The Lancet ( 18) 942 -952
2019
Visuomotor integration deficits are common to familial and sporadic preclinical Alzheimer's disease.
Sebastian J Crutch , Susie M D Henley , Ian B Malone , Carole H Sudre
Brain Communications (2020) (In press). 3 ( 1)
2021
Loss and Reorganisation of Superficial White Matter in Alzheimer's disease: A Diffusion MRI study
Ian B Malone , Jonathan M Schott , Nick C Fox , David M Cash
medRxiv
2021
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference
Alexandra L Young , Razvan V Marinescu , Neil P Oxtoby , Martina Bocchetta
Nature Communications 9 ( 1) 4273 -4273
216
2018
Disease-related cortical thinning in presymptomatic granulin mutation carriers.
Sergi Borrego-Écija , Roser Sala-Llonch , John van Swieten , Barbara Borroni
NeuroImage: Clinical 29 102540 -102540
2021
Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL–MRI: proof of concept
Catherine J Scott , Jieqing Jiao , Andrew Melbourne , Ninon Burgos
Journal of Cerebral Blood Flow and Metabolism 39 ( 12) 2419 -2432
7
2019
Plasma phospho‐tau181 in over 400 cognitively healthy 69‐ to 71‐year‐olds: Associations with cerebral amyloid, structural imaging and cognition in the Insight 46 study: Biomarkers (non‐neuroimaging): Multimodal biomarker studies in cognitively unimpaired cohorts
Ashvini Keshavan , Thomas K Karikari , Christopher A Lane , Thomas D Parker
Alzheimers & Dementia 16
2020
Vascular risk factors and amyloid pathology: Additive or interactive associations?: Vascular factors of Alzheimer's disease
Jonathan M Schott , Christopher A Lane , Jo Barnes , Sarah E Keuss
Alzheimers & Dementia 16
2020
Imaging endpoints for clinical trials in Alzheimer's disease.
David M Cash , Jonathan D Rohrer , Natalie S Ryan , Sebastien Ourselin
Alzheimer's Research & Therapy 6 ( 9) 87 -87
37
2014
Uncovering superficial white matter changes in young‐onset Alzheimer’s disease: Neuroimaging / New imaging methods
Thomas Veale , Ian B Malone , Teresa Poole , Thomas D Parker
Alzheimers & Dementia 16
2020
Mid‐life blood pressure and microstructural white matter: Findings from the 1946 British birth cohort: Neuroimaging: Earlier life risk factors and imaging biomarkers
Mathew Storey , Sarah‐Naomi James , Christopher A Lane , Jo Barnes
Alzheimers & Dementia 16
2020
Serum neurofilament light and whole brain volume associate with machine‐learning derived brain‐predicted age in the British 1946 birth cohort: Neuroimaging / New imaging methods
Aaron Wagen , William Coath , Sarah E Keuss , Sarah M Buchanan
Alzheimers & Dementia 16
2020
Comparison of static and dynamic analysis techniques for longitudinal analysis of amyloid PET: Neuroimaging / Optimal neuroimaging measures for tracking disease progression
David M Cash , Pawel J Markiewicz , Jieqing Jiao , William Coath
Alzheimers & Dementia 16
2020
Lifetime cigarette smoking and later‐life brain health: The population‐based 1946 British Birth Cohort: Public health: ADRD risk and protective factors: Brain changes and mechanisms
Sarah‐Naomi James , Christopher A Lane , Thomas D Parker , Ashvini Keshavan
Alzheimers & Dementia 16
2020
ExploreQC: A toolbox for MRI quality control in the EPAD multicentre study: Neuroimaging / New imaging methods
Juan Domingo Gispert , David M Cash , David L Thomas , Sjoerd Vos
Alzheimers & Dementia 16
2020
Dynamic PET imaging reduces sample sizes to detect longitudinal amyloid accumulation: Neuroimaging / Optimal neuroimaging measures for tracking disease progression
Isadora Lopes Alves , Lyduine Collij , Fiona Heeman , Jose Luis Molinuevo
Alzheimers & Dementia 16
1
2020
Amyloid Pattern Similarity Score (AMPSS): A reference region free measure of amyloid PET deposition in Alzheimer’s disease: Neuroimaging / New imaging methods
Lloyd Prosser , Thomas Veale , Ian B Malone , William Coath
Alzheimers & Dementia 16
2020